As described in Fig. 5a–c, results from colony formation and cell cycle analyses revealed that ML364 significantly enhanced the inhibitory effects of 17-AAG to hinder the cell cycle progression and curb the growth of breast cancer cells with ErbB2 overexpression. This evidence concerns the gene ERBB2 and breast carcinoma.